PP_1170x120_10-25-21

Johnson & Johnson’s single-shot COVID-19 vaccine

FDA panel endorses booster shot for J&J COVID vaccine

FDA panel endorses booster shot for J&J COVID vaccine

WASHINGTON — A panel of U.S. health advisers endorsed booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine Friday, saying they should be offered at least two months after immunization. J&J has requested the Food and Drug Administration for flexibility with its booster, arguing the extra dose adds important protection as early as two months after